12 overexpression induced by miR-16 dysregulation contributes to liver fibrosis by promoting autophagy in hepatic stellate cells

J Hepatol. 2018 Mar;68(3):493-504. doi: 10.1016/j.jhep.2017.10.011. Epub 2018 Jan 2.

Abstract

Background & aims: Hepatic stellate cells (HSCs) have a role in liver fibrosis. Guanine nucleotide-binding α-subunit 12 (Gα12) converges signals from G-protein-coupled receptors whose ligand levels are elevated in the environment during liver fibrosis; however, information is lacking on the effect of Gα12 on HSC trans-differentiation. This study investigated the expression of Gα12 in HSCs and the molecular basis of the effects of its expression on liver fibrosis.

Methods: 12 expression was assessed by immunostaining, and immunoblot analyses of mouse fibrotic liver tissues and primary HSCs. The role of Gα12 in liver fibrosis was estimated using a toxicant injury mouse model with Gα12 gene knockout and/or HSC-specific Gα12 delivery using lentiviral vectors, in addition to primary HSCs and LX-2 cells using microRNA (miR) inhibitors, overexpression vectors, or adenoviruses. miR-16, Gα12, and LC3 were also examined in samples from patients with fibrosis.

Results: 12 was overexpressed in activated HSCs and fibrotic liver, and was colocalised with desmin. In a carbon tetrachloride-induced fibrosis mouse model, Gα12 ablation prevented increases in fibrosis and liver injury. This effect was attenuated by HSC-specific lentiviral delivery of Gα12. Moreover, Gα12 activation promoted autophagy accompanying c-Jun N-terminal kinase-dependent ATG12-5 conjugation. In addition, miR-16 was found to be a direct inhibitor of the de novo synthesis of Gα12. Modulations of miR-16 altered autophagy in HSCs. In a fibrosis animal model or patients with severe fibrosis, miR-16 levels were lower than in their corresponding controls. Consistently, cirrhotic patient liver tissues showed Gα12 and LC3 upregulation in desmin-positive areas.

Conclusions: miR-16 dysregulation in HSCs results in Gα12 overexpression, which activates HSCs by facilitating autophagy through ATG12-5 formation. This suggests that Gα12 and its regulatory molecules could serve as targets for the amelioration of liver fibrosis.

Lay summary: Guanine nucleotide-binding α-subunit 12 (Gα12) is upregulated in activated hepatic stellate cells (HSCs) as a consequence of the dysregulation of a specific microRNA that is abundant in HSCs, facilitating the progression of liver fibrosis. This event is mediated by c-Jun N-terminal kinase-dependent ATG12-5 formation and the promotion of autophagy. We suggest that Gα12 and its associated regulators could serve as new targets in HSCs for the treatment of liver fibrosis.

Keywords: Activated stellate cell; G protein; Liver fibrosis; Lysosomal degradation; Non-coding RNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autophagy / drug effects
  • Cell Proliferation / drug effects
  • GTP-Binding Protein alpha Subunits, G12-G13 / antagonists & inhibitors
  • GTP-Binding Protein alpha Subunits, G12-G13 / metabolism*
  • Gene Expression Regulation
  • Hepatic Stellate Cells / metabolism*
  • Humans
  • Liver Cirrhosis* / metabolism
  • Liver Cirrhosis* / pathology
  • Mice
  • MicroRNAs / metabolism*
  • Plasminogen Activator Inhibitor 1 / metabolism
  • Plasminogen Activator Inhibitor 1 / pharmacology
  • Serine Proteinase Inhibitors / pharmacology
  • Signal Transduction / drug effects
  • Up-Regulation

Substances

  • MIRN16 microRNA, human
  • MicroRNAs
  • Mirn16 microRNA, mouse
  • Plasminogen Activator Inhibitor 1
  • Serine Proteinase Inhibitors
  • GTP-Binding Protein alpha Subunits, G12-G13